These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9474987)

  • 1. Unrelated donor bone marrow transplantation in Japanese patients is facilitated by the National Marrow Donor Program of the United States.
    Murata M; Haneda M; Nishida T; Kanie T; Hamaguchi M; Minami S; Kodera Y
    Transplant Proc; 1998 Feb; 30(1):150-2. PubMed ID: 9474987
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.
    Kernan NA; Bartsch G; Ash RC; Beatty PG; Champlin R; Filipovich A; Gajewski J; Hansen JA; Henslee-Downey J; McCullough J
    N Engl J Med; 1993 Mar; 328(9):593-602. PubMed ID: 8429851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved results in marrow transplantation from unrelated donors. Genoa BMT Group.
    Bacigalupo A; Lamparelli T; Barbanti M; Sacchi N; Battista Ferrara G; Pozzi S; Bregante S; Mordini N; Vitale V; Van Lint MT
    Haematologica; 1999 Jun; 84 Suppl EHA-4():50-2. PubMed ID: 10907467
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of 55 transplantations from unrelated volunteer donors facilitated by Tokai Marrow Donor Bank.
    Kodera Y; Morishima Y; Hirabayashi N; Tanimoto M; Matsuyama T; Horibe K; Mizuno S; Morishita Y; Yamauchi T; Yamada H; Sofue R; Shiobara S; Hamajima N; Kitaori K; Yazaki M; Nitta M; Saito H
    Intern Med; 1996 Jan; 35(1):78-83. PubMed ID: 8652948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis.
    Yagasaki H; Kojima S; Yabe H; Kato K; Kigasawa H; Sakamaki H; Tsuchida M; Kato S; Kawase T; Muramatsu H; Morishima Y; Kodera Y
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1603-8. PubMed ID: 19896085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.
    Perkins HA; Kollman C; Howe CW
    Clin Transpl; 1994; ():295-301. PubMed ID: 7547550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
    Fay JW; Nash RA; Wingard JR; Przepiorka D; Collins RH; Anasetti C; Devine SM; Piñeiro LA; Storb RF; Aro RM
    Transplant Proc; 1995 Feb; 27(1):1374. PubMed ID: 7533383
    [No Abstract]   [Full Text] [Related]  

  • 8. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
    McCurdy SR; Kasamon YL; Kanakry CG; Bolaños-Meade J; Tsai HL; Showel MM; Kanakry JA; Symons HJ; Gojo I; Smith BD; Bettinotti MP; Matsui WH; Dezern AE; Huff CA; Borrello I; Pratz KW; Gladstone DE; Swinnen LJ; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
    Haematologica; 2017 Feb; 102(2):391-400. PubMed ID: 27846611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FK506 for the prophylaxis of graft-versus-host-disease after bone marrow transplantation from HLA-genotypically mismatched unrelated donor].
    Nishida T; Haneda M; Kanie T; Murata M; Hamaguchi M; Minami S; Kodera Y
    Rinsho Ketsueki; 1998 Aug; 39(8):574-9. PubMed ID: 9785975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a regional bone marrow donor program.
    McCullough J; Scott EP; Halagan N; Strand RA; McGlave P
    JAMA; 1988 Jun; 259(22):3286-9. PubMed ID: 3286909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan.
    Yanada M; Emi N; Naoe T; Sakamaki H; Takahashi S; Hirabayashi N; Hiraoka A; Kanda Y; Tanosaki R; Okamoto S; Iwato K; Atsuta Y; Hamajima N; Tanimoto M; Kato S
    Bone Marrow Transplant; 2004 Aug; 34(4):331-7. PubMed ID: 15220958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
    Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F
    Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion.
    Harmon JV; Gruessner AC; Nakhleh RE; Zhang K; Gruessner RW
    Arch Surg; 2001 Jul; 136(7):817-21. PubMed ID: 11448397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated donor marrow transplantation: an interim analysis of the international marrow unrelated search and transplant (IMUST) Study. II.
    Howard MR; Hows JM; Gore SM; Bradley BA
    Bone Marrow Transplant; 1991; 7 Suppl 2():126. PubMed ID: 1878672
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors].
    Hamazaki T; Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Sasabe M; Kishimoto T; Inoue A; Kawa K
    Rinsho Ketsueki; 2000 May; 41(5):430-6. PubMed ID: 10879106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan.
    Goto T; Tanaka T; Sawa M; Ueda Y; Ago H; Chiba S; Kanamori H; Nishikawa A; Nougawa M; Ohashi K; Okumura H; Tanimoto M; Fukuda T; Kawashima N; Kato T; Okada K; Nagafuji K; Okamoto SI; Atsuta Y; Hino M; Tanaka J; Miyamura K
    Int J Hematol; 2018 Feb; 107(2):211-221. PubMed ID: 29027623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The National Marrow Donor Program: how it works, accomplishments to date.
    McCullough J; Hansen J; Perkins H; Stroncek D; Bartsch G
    Oncology (Williston Park); 1989 Feb; 3(2):63-8, 72; discussion 72-4. PubMed ID: 2701411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A preliminary analysis of unrelated marrow transplantations facilitated by the Japan Marrow Donor Program (JMDP)].
    Okamoto S; Harada M; Kato S; Morishima Y; Imamura M; Tsuchiya S; Yamada Y; Kodo H; Hoshi Y; Tsuchida M
    Rinsho Ketsueki; 1995 Jun; 36(6):524-9. PubMed ID: 7643445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye Movement Disorders Following Allogeneic Bone Marrow Transplantation on FK506 (Tacrolimus) and Ganciclovir.
    Karagun BS; Akbas T; Arpaci T; Antmen B
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):71-73. PubMed ID: 28731920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.